Arab World vs South Africa: Antiretroviral therapy coverage for PMTCT
Arab World
26.5%
in 2019
South Africa
98.0%
in 2024
Arab World rank
12th
South Africa rank
9th
Antiretroviral therapy coverage for PMTCT over time
- Arab World
- South Africa
How they compare
South Africa currently reports 98.0% against 26.5% in Arab World, a difference of 71.5%.
That makes South Africa's figure about 3.7 times Arab World's.
Across all 19 years both countries report, South Africa has been ahead every year.
Arab World ranks 12th and South Africa ranks 9th of 15 groups.
South Africa has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Arab World | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.1% | 28.3% | 26.2% | South Africa |
| 2010s | 18.5% | 96.7% | 78.1% | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Arab World or South Africa?
- South Africa, at 98.0% against 26.5% in Arab World as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Arab World and South Africa?
- 71.5%, with South Africa ahead.
- How many years of comparable data are there for Arab World and South Africa?
- 19 years are reported by both, from 2000 to 2019.
- How do Arab World and South Africa rank globally for antiretroviral therapy coverage for pmtct?
- Arab World ranks 12th and South Africa ranks 9th of 15 groups.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).